Evidence map›Paper›PMID 40497017›Full record

ArticleThe journal of allergy and clinical immunology. Global2025

Utility of serum cytokine testing to differentiate complicated common variable immunodeficiency in resource limited settings.

Aditi Jogdand, Karen M Gilbert, Joseph S Hong, Andrew J Pak, Katherine Liu, Uhuru Kamau, Neha V Khairnar, Henry C Ssemaganda, Daniel DiGiacomo, Sara Barmettler and 2 more

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Elevated IL-10 is Linked With the Expansion of T-betJournal of clinical immunology · 2026
    Article
  2. Article
  3. Quality and Safety Intervention: Improving Care of Patients Undergoing B Cell-Targeted Therapies.The journal of allergy and clinical immunology. In practice · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aditi JogdandClinical Immunodeficiency Program of Beth Israel Lahey Health, Division of Allergy and Immunology, Lahey Hospital and Medical Center, Burlington, Mass.
Karen M GilbertDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Mass.
Joseph S HongDivision of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
Andrew J PakDivision of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
Katherine LiuDivision of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
Uhuru KamauComparative Effectiveness Research Institute, Lahey Hospital and Medical Center, Burlington, Mass.
Neha V KhairnarComparative Effectiveness Research Institute, Lahey Hospital and Medical Center, Burlington, Mass.
Henry C SsemagandaComparative Effectiveness Research Institute, Lahey Hospital and Medical Center, Burlington, Mass.
Daniel DiGiacomoDepartment of Pediatrics, K. Hovnanian Children's Hospital, Jersey Shore University Medical Center, Neptune, NJ.
Sara BarmettlerDivision of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
Mei-Sing OngDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Mass.
Jocelyn R FarmerClinical Immunodeficiency Program of Beth Israel Lahey Health, Division of Allergy and Immunology, Lahey Hospital and Medical Center, Burlington, Mass.

Funding

Underdiagnosis of primary immunodeficiency disorders: Recognize and EducateR01MD017816 · NIMHD · HARVARD PILGRIM HEALTH CARE, INC. · PI Jocelyn R Farmer, Mei-Sing Ong · 2022 to 2026
$3.2M
NIMHD NIH HHS R01 MD017816
6 · The paper itself

Abstract

Background: Common variable immunodeficiency (CVID) is the most common, symptomatic inborn error of immunity (IEI) worldwide. CVID diagnosis requires lymphocyte subset analysis by flow cytometry to delineate risk for autoimmune and inflammatory (AI) disease, known as complicated CVID. In resource-limited settings, reduced access to flow cytometry limits CVID diagnostics. Objectives: We investigated the utility of serum cytokine testing, as compared to standard-of-care flow cytometry, for the diagnosis of AI disease in IEI and CVID. Methods: We performed a retrospective review of patients with Results: In IEI and CVID, higher sIL-2R and IL-10 levels correlated with more AI complications per patient and more severe T-cell immunophenotypes. Composite receiver-operating characteristic curves for sIL-2R and IL-10, as compared to lymphocyte subsets (naive CD4 Conclusions: sIL-2R and IL-10 testing had statistically comparable diagnostic performance for complicated CVID as compared to the current standard-of-care using flow cytometry.

Indexed as

AIautoimmune and inflammatoryautoinflammationCommon variable immunodeficiencycomplicated common variable immunodeficiencyCVIDCVIDccytokinesflow cytometryIEIIL-10inborn error of immunityresource-limited care settingsoluble biomarkerssoluble IL-2 receptor (sIL-2R)

Identifiers

PMID40497017
PMCPMC12150043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.